Sigma-Aldrich (FRA:SIQ) Total Liabilities : €952 Mil (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Sigma-Aldrich Total Liabilities?

Sigma-Aldrich's Total Liabilities for the quarter that ended in Sep. 2015 was €952 Mil.

Sigma-Aldrich's quarterly Total Liabilities increased from Mar. 2015 (€871.33 Mil) to Jun. 2015 (€889.22 Mil) and increased from Jun. 2015 (€889.22 Mil) to Sep. 2015 (€951.59 Mil).

Sigma-Aldrich's annual Total Liabilities declined from Dec. 2012 (€970.79 Mil) to Dec. 2013 (€664.30 Mil) but then increased from Dec. 2013 (€664.30 Mil) to Dec. 2014 (€863.72 Mil).

Sigma-Aldrich Total Liabilities Historical Data

The historical data trend for Sigma-Aldrich's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma-Aldrich Total Liabilities Chart

Sigma-Aldrich Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Total Liabilities

Get a 7-Day Free Trial

784.73

822.32

970.79

664.30

863.72

Sigma-Aldrich Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Liabilities	Get a 7-Day Free Trial															693.74	863.72	871.33	889.22	951.59

Sigma-Aldrich Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sigma-Aldrich's Total Liabilities for the fiscal year that ended in Dec. 2014 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	397.39	+	(243.3	+	83.533
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	55.959	+	83.533)
	=	864

Total Liabilities	=	Total Assets (A: Dec. 2014 )	-	Total Equity (A: Dec. 2014 )
	=	3402.145	-	2538.43
	=	864

Sigma-Aldrich's Total Liabilities for the quarter that ended in Sep. 2015 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	449.955	+	(267.3	+	58.806
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	83.754	+	91.773)
	=	952

Total Liabilities	=	Total Assets (Q: Sep. 2015 )	-	Total Equity (Q: Sep. 2015 )
	=	3943.566	-	2991.978
	=	952

Sigma-Aldrich Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sigma-Aldrich's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma-Aldrich (FRA:SIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sigma-Aldrich Corp (FRA:SIQ) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sigma-aldrich.com

Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de HaÃ«n, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.

Sigma-Aldrich (FRA:SIQ) Headlines

No Headlines